Mortality in first-episode HIV-associated cryptococcal meningitis in Peru

Cryptococcal meningitis (CM) remains one of the leading causes of morbidity and mortality among people living with HIV, particularly in low and middle-income countries where access to standard antifungal therapy is limited. Despite global advances in HIV care, early diagnosis and effective treatment...

Descripción completa

Guardado en:
Autores principales: Juan José Montenegro-Idrogo, Luz A. Quispe-Gárate, Blanca Salazar, Sami Alcedo, Paola L Rondan, Jorge Arévalo, Alfredo Chiappe-Gonzalez, Jaime Soria
Formato: Artículo
Lenguaje:inglés
Publicado: 2025
Materias:
Medicine
Cryptococcal meningitis
Proportional hazards model
Referral
Fluconazole
Cryptococcosis
Cohort
Mortality rate
Retrospective cohort study
Hazard ratio
Pediatrics
Internal medicine
Cryptococcus
Meningitis
Disease
Antiretroviral therapy
Risk of mortality
Cohort study
Intensive care medicine
Survival analysis
Human immunodeficiency virus (HIV)
Antifungal
Young adult
Cryptococcus neoformans
Case fatality rate
Cause of death
Burden of disease
Epidemiology
Expanded access
Mycosis
Sida
Coinfection
Adult
Antifungal Agents therapeutic use
Female
Humans
Male
Middle Aged
Peru epidemiology
Retrospective Studies
HIV Infections complications
Survival Analysis
Meningitis, Cryptococcal drug therapy
Meningitis, Cryptococcal mortality
AIDS-Related Opportunistic Infections drug therapy
AIDS-Related Opportunistic Infections mortality
Health Sciences Medicine Epidemiology Fungal Infections and Studies
Health Sciences Medicine Epidemiology Nail Diseases and Treatments
Physical Sciences Environmental Science Health, Toxicology and Mutagenesis Insects and Parasite Interactions
Acceso en línea:Ver en el sistema de origen
Enlace permanente (DOI o Handle)
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Sea el primero en dejar un comentario!
Para ver esta página, ingrese con su cuenta.

Ejemplares similares